CCR2 and pulmonary arterial hypertension: The goal is to track the dynamic changes in the incidence of resident CCR2- and monocyte-derived CCR2+ macrophages in the RV tissue throughout the progression of PAH, particularly during the transition from compensated to decompensated RV remodelling.